The market for computed tomography devices in South Korea is well-established and technologically advanced, supported by a universal healthcare system recognized for its efficiency, innovation, and comprehensive coverage. The market continues to evolve, driven by demographic shifts, a growing prevalence of chronic illnesses, and sustained government investment in healthcare infrastructure and digital transformation. An aging population and the increasing incidence of chronic conditions are key factors fueling demand for CT imaging solutions. These diseases remain the leading cause of mortality and require sophisticated diagnostic capabilities for effective clinical intervention. For example, a study published in Endocrinology and Metabolism (April 2025) reported that in 2022, 30% of South Korean adults were affected by hypertension, while 15.5% of individuals over the age of 30 were living with diabetes. These figures reflect a consistent need for high-precision diagnostic tools to support ongoing patient care. South Korea’s strategic focus on innovation and infrastructure modernization further strengthens the outlook for the CT market. Government-led initiatives aimed at enhancing medical technology adoption and expanding access to advanced imaging across healthcare institutions are expected to accelerate market growth. Therefore, South Korea’s CT devices market is positioned for sustained expansion, supported by a technologically progressive healthcare system, rising diagnostic demand, and proactive government policies that prioritize innovation and infrastructure enhancement.